vs
Side-by-side financial comparison of ARGENX SE (ARGX) and F&G Annuities & Life, Inc. (FG). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.8B, roughly 1.4× F&G Annuities & Life, Inc.). ARGENX SE runs the higher net margin — 35.5% vs 7.3%, a 28.2% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 13.2%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
F&G Annuities & Life, Inc. is a public company headquartered in Des Moines, Iowa. It primarily provides annuities, life insurance, and pension buyout services. The company was founded in 1959.
ARGX vs FG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $1.8B |
| Net Profit | $877.2M | $128.0M |
| Gross Margin | 89.5% | — |
| Operating Margin | 28.9% | — |
| Net Margin | 35.5% | 7.3% |
| Revenue YoY | 83.2% | 13.2% |
| Net Profit YoY | 1.3% | -60.9% |
| EPS (diluted) | $13.25 | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $1.8B | $1.4B | ||
| Q1 25 | — | $908.0M | ||
| Q4 24 | $1.4B | $1.6B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $901.9M | $1.2B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | $877.2M | $128.0M | ||
| Q3 25 | — | $118.0M | ||
| Q2 25 | $414.8M | $40.0M | ||
| Q1 25 | — | $-21.0M | ||
| Q4 24 | $865.6M | $327.0M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | $-32.5M | $203.0M | ||
| Q1 24 | — | $115.0M |
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 89.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 89.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | 28.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 19.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -15.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | 35.5% | 7.3% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | 23.4% | 2.9% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | 64.1% | 21.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | -3.6% | 17.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | $13.25 | $0.97 | ||
| Q3 25 | — | $0.85 | ||
| Q2 25 | $6.32 | $0.26 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | $13.33 | $2.53 | ||
| Q3 24 | — | $-0.08 | ||
| Q2 24 | $-0.55 | $1.55 | ||
| Q1 24 | — | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $1.5B |
| Total DebtLower is stronger | — | $2.2B |
| Stockholders' EquityBook value | $7.3B | $4.8B |
| Total Assets | $8.7B | $98.4B |
| Debt / EquityLower = less leverage | — | 0.47× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | $1.5B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $2.1B | $1.9B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | $1.5B | $2.3B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | $1.4B | $3.5B | ||
| Q1 24 | — | $2.4B |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $11.0M | $2.0B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | $7.3B | $4.8B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | $6.1B | $4.4B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | $5.5B | $4.0B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | $4.3B | $3.7B | ||
| Q1 24 | — | $3.5B |
| Q4 25 | $8.7B | $98.4B | ||
| Q3 25 | — | $96.1B | ||
| Q2 25 | $7.2B | $91.8B | ||
| Q1 25 | — | $88.0B | ||
| Q4 24 | $6.2B | $85.0B | ||
| Q3 24 | — | $84.1B | ||
| Q2 24 | $4.8B | $78.5B | ||
| Q1 24 | — | $74.4B |
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | 0.00× | 0.56× | ||
| Q1 24 | — | 0.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $1.2B |
| Free Cash FlowOCF − Capex | $322.4M | — |
| FCF MarginFCF / Revenue | 13.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.37× | 9.13× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | $1.2B | ||
| Q3 25 | — | $937.0M | ||
| Q2 25 | $361.8M | $1.6B | ||
| Q1 25 | — | $956.0M | ||
| Q4 24 | $41.9M | $1.3B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $-124.7M | $1.1B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | $322.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $356.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-125.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | 13.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -13.9% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.37× | 9.13× | ||
| Q3 25 | — | 7.94× | ||
| Q2 25 | 0.87× | 40.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.05× | 4.04× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.20× | ||
| Q1 24 | — | 13.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
